Biggest News Aggregation in the World
📰 Exploratory Analyses News

Exploratory Analyses News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Exploratory Analyses. Real-time updates on events, politics, business and more.

NANOBIOTIX Announces Updated Preliminary Results From Phase 1 Pancreatic Cancer Trial and New Exploratory Analysis From Completed Phase 1 Head and Neck Cancer Trial at ESMO 2023

Strategic Collaborator-presented Phase 1 Pancreatic Cancer Data An ongoing Phase 1, collaborator-led study of NBTXR3 in locally advanced pancreatic cancer established a favorable safety profile and...
United States France General United Kingdom New York Pierre Louis Germain Christophe Le Tourneau

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial | Critical Care Medicine | JAMA

This open label clinical trial compares the effects of dexamethasone vs usual care on the number of days alive and free of mechanical ventilation at day 28 amon
United States Moinhos De Vento Juazeiro Do Norte Nereu Ramos Santa Catarina Duke University

PathAI to Present Recent Advances in Applying AI-Powered Pathology Towards Liver Disease at the Amer

BOSTON--(BUSINESS WIRE)--#TLM22--PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, today announced that the organization’s recent research will be presented at the upcoming 2022 AASLD 2022 Liver Meeting*, which will be held in Washington, D.C. from November 4-8, 2022. At this...
United States Mike Montalto Gilead Sciences Novo Nordisk Chief Scientific Officer Multi Stain Machine Learning Method

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial | Infectious Diseases | JAMA

This randomized trial assesses the effect of a single dose of subcutaneous casirivimab and imdevimab antibody combination vs placebo on 28-day progression to sy
Eteläuomen Läi United States South Africa Vocs Vois Van Elteren Meaganp Obrien

Seagen Announces Updated Results from Pivotal HER2CLIMB Trial Evaluating TUKYSA® (tucatinib) in Pati

– Exploratory Analyses from the Pivotal HER2CLIMB Trial Show Patients with Stable and Active Brain Metastases Treated with a TUKYSA Regimen Maintained a Survival Benefit After Additional 15.6 Months of Follow-Up –BOTHELL, Wash.--(BUSINESS WIRE)--#SABCS2021--Seagen Inc. (Nasdaq:SGEN) today announced the presentation...
United States United Kingdom David Caouette Nancyu Lin Rogerd Dansey Peggy Pinkston

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science